Beta-Blocker Drug Therapy Reduces Secondary Cancer Formation in Breast Cancer and Improves Cancer Specific Survival-Reference-Cited by-同舟云学术

Beta-Blocker Drug Therapy Reduces Secondary Cancer Formation in Breast Cancer and Improves Cancer Specific Survival

Published:2010-10-19 Issue:7 Volume:1 Page:628-638
ISSN:1949-2553
Container-title:Oncotarget
language:en
Short-container-title:Oncotarget

Author:

Powe Desmond G.¹,Voss Melanie J.²,Zänker Kurt S.²,Habashy Hany O.³,Green Andrew R.³,Ellis Ian O.³,Entschladen Frank²

Affiliation:

1. Department of Cellular Pathology, Queen's Medical Centre, Nottingham University Hospitals NHS Trust, Nottingham, NG7 2UH, UK and The John van Geest Cancer Research Centre School of Science and Technology, Nottingham Trent University, Clifton Lane, Nottingham NG11 8NS UK

2. Institute of Immunology, University of Witten/Herdecke, DE-58448, Witten, Germany

3. School of Molecular Medical Sciences, University of Nottingham, Nottingham, NG7 2UH, UK

Publisher

Impact Journals, LLC

Subject

Oncology

Cited by 401 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Targeting the peripheral neural-tumour microenvironment for cancer therapy;Nature Reviews Drug Discovery;2024-09-06

2. The multifaceted role of beta‐blockers in overcoming cancer progression and drug resistance: Extending beyond cardiovascular disorders;The FASEB Journal;2024-07-08

3. Congenital Vascular and Lymphatic Diseases;Circulation Research;2024-06-21

4. Role of transforming growth factor-β1 pathway in angiogenesis induced by chronic stress in colorectal cancer;Cancer Biology & Therapy;2024-06-10

5. Beta-blocker use and breast cancer outcomes: a meta-analysis;Breast Cancer Research and Treatment;2024-06-05